2023-08-15 07:00:59 ET
More on Cardinal Health
- Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation
- Cardinal Health: Focus On Core Strengths And Operational Efficiency Enabling Margin Expansion
- Cardinal Health: Not A Long-Term Investment
- Cardinal Health Q4 2023 Earnings Preview
- Supreme Court to hear arguments on Purdue Pharma $6B bankruptcy settlement
- Cardinal updates forecast, plans to buy back at least $2B shares over 3 years
- Cardinal Health to merge Outcomes business into TDS for minority stake
- Seeking Alpha’s Quant Rating on Cardinal Health
- Earnings data for Cardinal Health
- Dividend scorecard for Cardinal Health
For further details see:
Cardinal Health Non-GAAP EPS of $1.55 beats by $0.07, revenue of $53.5B beats by $810M